BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma
Chiaki Tsuge Ishida(Columbia University Irving Medical Center), Markus D. Siegelin(Columbia University Irving Medical Center)
Cited by 42
Related Papers
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
|Journal of Clinical Investigation|2020|204
TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2015|65
Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2016|56